Percutaneous coronary intervention (PCI) is effective in opening the infarct related artery
and restoring thrombolysis in myocardial infarction flow 3 (TIMI-flow 3) in large majority of ST …

OBJECTIVES We sought to elucidate the long-term prognostic importance of angiographic
no-reflow phenomenon after percutaneous transluminal coronary angioplasty (PTCA) for …

We found that of 1,192 patients who underwent primary percutaneous coronary intervention
and who had final Thrombolysis In Myocardial Infarction grade 3 flow at the conclusion of the …

The no-reflow phenomenon has been shown to have a significant effect on clinical
outcomes in patients with acute ST-segment elevation myocardial infarction. Angiographic …

The no reflow phenomenon is reported to occur in> 2% of all percutaneous coronary
interventions (PCIs) and portends a poor prognosis. We analyzed data from 5,286 …

Aims The aim of the study was to evaluate long-term outcomes of transient versus persistent
no-reflow. Methods and results A total of 17,547 patients with normal flow post percutaneous …

BACKGROUND: No randomized trial has been conducted to compare different vasodilators
for treating no-reflow during primary percutaneous coronary intervention (PCI) for ST …

No-reflow is responsible for 40% of the primary percutaneous coronary intervention without
complete myocardial reperfusion despite successful reopening of the infarct-related artery …

Background No-reflow is associated with an adverse outcome and higher mortality in
patients with ST-segment elevation acute myocardial infarction (STEMI) who undergo …

Background Many factors are associated with no‐reflow (NRF) phenomenon in ST‐segment
elevation myocardial infarction (STEMI), including plasma glucose, age, and pre …